Literature DB >> 24042167

How microRNAs influence both hereditary and inflammatory-mediated colon cancers.

Jennifer Hutchison1, Zoe Cohen, Benjamin C Onyeagucha, Janet Funk, Mark A Nelson.   

Abstract

MicroRNAs have emerged as important post-translational regulators of gene expression and are involved in several physiological and pathological states including the pathogenesis of human colon cancers. In regards to tumor development, microRNAs can act as oncogenes or tumor suppressors. Two hereditary predispositions (i.e., Lynch syndrome and familial adenomatous polyposis) contribute to the development of colon cancer. In addition, individuals who suffer from inflammatory bowel diseases such as Crohn's disease or ulcerative colitis have a higher risk of developing colon cancer. Here, we discuss the occurrence of the deregulated expression of microRNAs in colon cancer that arise as a result of hereditary predisposition and inflammatory bowel disease.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Crohn’s disease; FAP; HNPCC; MicroRNA; ulcerative colitis

Mesh:

Substances:

Year:  2013        PMID: 24042167      PMCID: PMC3893936          DOI: 10.1016/j.cancergen.2013.06.005

Source DB:  PubMed          Journal:  Cancer Genet


  76 in total

1.  Cutting edge: a variant of the IL-23R gene associated with inflammatory bowel disease induces loss of microRNA regulation and enhanced protein production.

Authors:  Antonie Zwiers; Laurens Kraal; Tineke C T M van de Pouw Kraan; Thomas Wurdinger; Gerd Bouma; Georg Kraal
Journal:  J Immunol       Date:  2012-01-18       Impact factor: 5.422

2.  Trends in colorectal cancer screening with home-based fecal occult blood tests in adults ages 50 to 64 years, 2000-2008.

Authors:  Priti Bandi; Vilma Cokkinides; Robert A Smith; Ahmedin Jemal
Journal:  Cancer       Date:  2012-03-20       Impact factor: 6.860

3.  Modulation of mismatch repair and genomic stability by miR-155.

Authors:  Nicola Valeri; Pierluigi Gasparini; Muller Fabbri; Chiara Braconi; Angelo Veronese; Francesca Lovat; Brett Adair; Ivan Vannini; Francesca Fanini; Arianna Bottoni; Stefan Costinean; Sukhinder K Sandhu; Gerard J Nuovo; Hansjuerg Alder; Roberta Gafa; Federica Calore; Manuela Ferracin; Giovanni Lanza; Stefano Volinia; Massimo Negrini; Michael A McIlhatton; Dino Amadori; Richard Fishel; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-29       Impact factor: 11.205

4.  Role of primary miRNA polymorphic variants in metastatic colon cancer patients treated with 5-fluorouracil and irinotecan.

Authors:  V Boni; R Zarate; J C Villa; E Bandrés; M A Gomez; E Maiello; J Garcia-Foncillas; E Aranda
Journal:  Pharmacogenomics J       Date:  2010-06-29       Impact factor: 3.550

5.  Socioeconomic status and the risk of colorectal cancer: an analysis of more than a half million adults in the National Institutes of Health-AARP Diet and Health Study.

Authors:  Chyke A Doubeni; Adeyinka O Laiyemo; Jacqueline M Major; Mario Schootman; Min Lian; Yikyung Park; Barry I Graubard; Albert R Hollenbeck; Rashmi Sinha
Journal:  Cancer       Date:  2012-01-03       Impact factor: 6.860

Review 6.  Alterations of microRNAs contribute to colon carcinogenesis.

Authors:  Aaron J Schetter; Curtis C Harris
Journal:  Semin Oncol       Date:  2011-12       Impact factor: 4.929

7.  Identification of microRNAs associated with ileal and colonic Crohn's disease.

Authors:  Feng Wu; Simin Zhang; Themistocles Dassopoulos; Mary L Harris; Theodore M Bayless; Stephen J Meltzer; Steven R Brant; John H Kwon
Journal:  Inflamm Bowel Dis       Date:  2010-10       Impact factor: 5.325

8.  Mutator activity induced by microRNA-155 (miR-155) links inflammation and cancer.

Authors:  Esmerina Tili; Jean-Jacques Michaille; Dorothee Wernicke; Hansjuerg Alder; Stefan Costinean; Stefano Volinia; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-07       Impact factor: 11.205

9.  The Role of MicroRNA in Inflammatory Bowel Disease.

Authors:  Sushila R Dalal; John H Kwon
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-11

10.  A microRNA, miR-101a, controls mammary gland development by regulating cyclooxygenase-2 expression.

Authors:  Tetsuya Tanaka; Shingo Haneda; Kazuhiko Imakawa; Senkiti Sakai; Kentaro Nagaoka
Journal:  Differentiation       Date:  2008-11-20       Impact factor: 3.880

View more
  12 in total

1.  Role of microRNAs in resveratrol-mediated mitigation of colitis-associated tumorigenesis in Apc(Min/+) mice.

Authors:  Ibrahim Altamemi; E Angela Murphy; James F Catroppo; Elizabeth E Zumbrun; Jiajia Zhang; Jamie L McClellan; Udai P Singh; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  J Pharmacol Exp Ther       Date:  2014-05-09       Impact factor: 4.030

Review 2.  Genetics and Genetic Biomarkers in Sporadic Colorectal Cancer.

Authors:  John M Carethers; Barbara H Jung
Journal:  Gastroenterology       Date:  2015-07-26       Impact factor: 22.682

Review 3.  Molecular approach to genetic and epigenetic pathogenesis of early-onset colorectal cancer.

Authors:  Gulcin Tezcan; Berrin Tunca; Secil Ak; Gulsah Cecener; Unal Egeli
Journal:  World J Gastrointest Oncol       Date:  2016-01-15

Review 4.  MicroRNAs as biomarkers and prospective therapeutic targets in colon and pancreatic cancers.

Authors:  Ganji Purnachandra Nagaraju; Appiya Santharam Madanraj; Sheik Aliya; Balney Rajitha; Olatunji Boladale Alese; Ekamber Kariali; Afroz Alam; Bassel F El-Rayes
Journal:  Tumour Biol       Date:  2015-11-04

Review 5.  Role of epithelial-mesenchymal transition in gastric cancer initiation and progression.

Authors:  Zhao Peng; Chen-Xiao Wang; Er-Hu Fang; Guo-Bin Wang; Qiang Tong
Journal:  World J Gastroenterol       Date:  2014-05-14       Impact factor: 5.742

Review 6.  The fusion of two worlds: non-coding RNAs and extracellular vesicles--diagnostic and therapeutic implications (Review).

Authors:  Yukie Sato-Kuwabara; Sonia A Melo; Fernando A Soares; George A Calin
Journal:  Int J Oncol       Date:  2014-10-17       Impact factor: 5.650

7.  miR-1238 inhibits cell proliferation by targeting LHX2 in non-small cell lung cancer.

Authors:  Xiangguang Shi; Lei Zhan; Can Xiao; Zhe Lei; Haiping Yang; Longqiang Wang; Jun Zhao; Hong-Tao Zhang
Journal:  Oncotarget       Date:  2015-08-07

8.  MicroRNA-645 is an oncogenic regulator in colon cancer.

Authors:  S T Guo; X Y Guo; J Wang; C Y Wang; R H Yang; F H Wang; X Y Li; H Hondermarck; R F Thorne; Y F Wang; L Jin; X D Zhang; C C Jiang
Journal:  Oncogenesis       Date:  2017-05-15       Impact factor: 7.485

Review 9.  Tumor suppressor genes in familial adenomatous polyposis.

Authors:  Nahal Eshghifar; Naser Farrokhi; Tahereh Naji; Mohammadreza Zali
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2017

10.  Expression of MCRS1 and MCRS2 and their correlation with serum carcinoembryonic antigen in colorectal cancer.

Authors:  Chenguang Li; Mingxiao Chen; Pingwei Zhao; Desalegn Admassu Ayana; Lei Wang; Yanfang Jiang
Journal:  Exp Ther Med       Date:  2016-06-03       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.